Occlusive treatment enhances efficacy of tacrolimus 0.1% in a pediatric patient with severe alopecia areata: Case report and literature review.
Pediatr Dermatol
; 38(1): 339-340, 2021 Jan.
Article
en En
| MEDLINE
| ID: mdl-33247446
Tacrolimus is an immunomodulatory drug, available for topical and systemic treatment of several dermopathies that are characterized by immune dysregulation. In the case of alopecia areata, standard application has proven insufficient to yield satisfactory results. Herein, we present a 6-year-old patient with Down syndrome who was treated with topical tacrolimus 0.1% ointment under occlusion overnight with remarkable clinical improvement within 4 months.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Tacrolimus
/
Alopecia Areata
Tipo de estudio:
Systematic_reviews
Límite:
Child
/
Humans
Idioma:
En
Revista:
Pediatr Dermatol
Año:
2021
Tipo del documento:
Article
País de afiliación:
Brasil
Pais de publicación:
Estados Unidos